Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Moreno

Showing results (441-450 of 548) with videos related to

Pageof 55
Sort By:
International Journal of Cancer|April 6, 2017
Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control studyDora Romaguera, Esther Gracia-Lavedan, Amaia Molinuevo, et al.
Nutrients|June 26, 2019
Dietary Inflammatory Index, Dietary Non-Enzymatic Antioxidant Capacity, and Colorectal and Breast Cancer Risk (MCC-Spain Study)Mireia Obón-Santacana, Dora Romaguera, Esther Gracia-Lavedan, et al.
Blood|July 28, 2005
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival predictionSilvia Bea, Andreas Zettl, George Wright, et al.
International Journal of Cancer|November 1, 2021
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein in testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation studySophie Cousin, Jean-Yves Blay, Irene Braña Garcia, et al.
International Journal of Cancer|July 29, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere lengthDaniele Campa, Alessandro Martino, Judit Varkonyi, et al.
Environment International|September 23, 2022
Toenail zinc as a biomarker: Relationship with sources of environmental exposure and with genetic variability in MCC-Spain studyEnrique Gutiérrez-González, Pablo Fernández-Navarro, Roberto Pastor-Barriuso, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 20, 2021
Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancerDora Romaguera, Sílvia Fernández-Barrés, Esther Gracia-Lavedán, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2026
Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia ProgressionBlanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, Pekka Keski-Rahkonen, et al.
International Journal of Cancer|June 16, 2023
Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain)Anna Palomar-Cros, Kurt Straif, Dora Romaguera, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumorsKristoffer Staal Rohrberg, Ignacio Melero, Miguel F Sanmamed, et al.
Pageof 55

Showing results (441-450 of 548) with videos related to

Sort By:
Pageof 55
International Journal of Cancer|April 6, 2017
Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control studyDora Romaguera, Esther Gracia-Lavedan, Amaia Molinuevo, et al.
Nutrients|June 26, 2019
Dietary Inflammatory Index, Dietary Non-Enzymatic Antioxidant Capacity, and Colorectal and Breast Cancer Risk (MCC-Spain Study)Mireia Obón-Santacana, Dora Romaguera, Esther Gracia-Lavedan, et al.
Blood|July 28, 2005
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival predictionSilvia Bea, Andreas Zettl, George Wright, et al.
International Journal of Cancer|November 1, 2021
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein in testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation studySophie Cousin, Jean-Yves Blay, Irene Braña Garcia, et al.
International Journal of Cancer|July 29, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere lengthDaniele Campa, Alessandro Martino, Judit Varkonyi, et al.
Environment International|September 23, 2022
Toenail zinc as a biomarker: Relationship with sources of environmental exposure and with genetic variability in MCC-Spain studyEnrique Gutiérrez-González, Pablo Fernández-Navarro, Roberto Pastor-Barriuso, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 20, 2021
Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancerDora Romaguera, Sílvia Fernández-Barrés, Esther Gracia-Lavedán, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2026
Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia ProgressionBlanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, Pekka Keski-Rahkonen, et al.
International Journal of Cancer|June 16, 2023
Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain)Anna Palomar-Cros, Kurt Straif, Dora Romaguera, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumorsKristoffer Staal Rohrberg, Ignacio Melero, Miguel F Sanmamed, et al.
Pageof 55